Kiyoshi Oketani

519 total citations
22 papers, 446 citations indexed

About

Kiyoshi Oketani is a scholar working on Surgery, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Kiyoshi Oketani has authored 22 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 8 papers in Molecular Biology and 4 papers in Organic Chemistry. Recurrent topics in Kiyoshi Oketani's work include Helicobacter pylori-related gastroenterology studies (11 papers), Glycosylation and Glycoproteins Research (3 papers) and Pharmacological Effects of Natural Compounds (3 papers). Kiyoshi Oketani is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (11 papers), Glycosylation and Glycoproteins Research (3 papers) and Pharmacological Effects of Natural Compounds (3 papers). Kiyoshi Oketani collaborates with scholars based in Japan. Kiyoshi Oketani's co-authors include Manabu Murakami, Hideaki Fujisaki, Tsuneo Wakabayashi, Takashi Inoue, Isao Yamatsu, Noriaki Takeguchi, Hajime Shibata, Masatoshi Fujimoto, Hideki Sakai and Makoto Yamaguchi and has published in prestigious journals such as Journal of Medicinal Chemistry, British Journal of Pharmacology and Biochemical Pharmacology.

In The Last Decade

Kiyoshi Oketani

21 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kiyoshi Oketani Japan 11 169 145 75 73 69 22 446
J. Fryklund Sweden 13 338 2.0× 274 1.9× 156 2.1× 130 1.8× 77 1.1× 24 705
B. Elander Sweden 9 257 1.5× 382 2.6× 278 3.7× 127 1.7× 40 0.6× 12 768
Wen Yan United States 14 316 1.9× 83 0.6× 31 0.4× 53 0.7× 146 2.1× 19 658
M Armstrong United States 9 204 1.2× 200 1.4× 13 0.2× 257 3.5× 77 1.1× 11 651
Bob D. Rush United States 14 200 1.2× 56 0.4× 16 0.2× 152 2.1× 91 1.3× 21 663
Akifumi Kogame Japan 9 186 1.1× 127 0.9× 27 0.4× 50 0.7× 24 0.3× 14 380
Carolina Cerré Italy 16 114 0.7× 164 1.1× 22 0.3× 345 4.7× 40 0.6× 23 575
Colin J. Theobald United Kingdom 13 243 1.4× 107 0.7× 20 0.3× 33 0.5× 142 2.1× 18 464
Marie Besancon United States 14 442 2.6× 394 2.7× 331 4.4× 124 1.7× 48 0.7× 17 810
Ulrike Gutjahr Germany 15 234 1.4× 205 1.4× 24 0.3× 505 6.9× 27 0.4× 15 759

Countries citing papers authored by Kiyoshi Oketani

Since Specialization
Citations

This map shows the geographic impact of Kiyoshi Oketani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kiyoshi Oketani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kiyoshi Oketani more than expected).

Fields of papers citing papers by Kiyoshi Oketani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kiyoshi Oketani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kiyoshi Oketani. The network helps show where Kiyoshi Oketani may publish in the future.

Co-authorship network of co-authors of Kiyoshi Oketani

This figure shows the co-authorship network connecting the top 25 collaborators of Kiyoshi Oketani. A scholar is included among the top collaborators of Kiyoshi Oketani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kiyoshi Oketani. Kiyoshi Oketani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matsuoka, Katsuyoshi, Makoto Naganuma, Toshifumi Hibi∥, et al.. (2021). Phase 1 study on the safety and efficacy of E6011, antifractalkine antibody, in patients with Crohn's disease. Journal of Gastroenterology and Hepatology. 36(8). 2180–2186. 15 indexed citations
2.
Sakai, Hideki, et al.. (2002). E3040 sulphate, a novel thromboxane synthase inhibitor, blocks the Cl− secretion induced by platelet‐activating factor in isolated rat colon. British Journal of Pharmacology. 136(3). 383–390. 10 indexed citations
3.
Oketani, Kiyoshi, et al.. (2001). In vitro effects of E3040, a dual inhibitor of 5-lipoxygenase and thromboxane A2 synthetase, on eicosanoid production. European Journal of Pharmacology. 422(1-3). 209–216. 22 indexed citations
4.
Oketani, Kiyoshi, Takashi Inoue, & Manabu Murakami. (2001). Effect of E3040, an inhibitor of 5-lipoxygenase and thromboxane synthase, on rat bowel damage induced by lipopolysaccharide. European Journal of Pharmacology. 427(2). 159–166. 28 indexed citations
5.
Fujisaki, Hideaki, et al.. (1998). Effects of Rabeprazole, a Gastric Proton Pump Inhibitor, on Biliary and Hepatic Lysosomal Enzymes in Rats. The Japanese Journal of Pharmacology. 76(3). 279–288. 8 indexed citations
6.
Hibi, Shigeki, Yasushi Okamoto, Katsuya Tagami, et al.. (1994). Novel Dual Inhibitors of 5-Lipoxygenase and Thromboxane A2 Synthetase: Synthesis and Structure-Activity Relationships of 3-Pyridylmethyl-Substituted 2-Amino-6-hydroxybenzothiazole Derivatives. Journal of Medicinal Chemistry. 37(19). 3062–3070. 31 indexed citations
7.
Fujisaki, Hideaki, Kiyoshi Oketani, Hajime Shibata, et al.. (1993). Inhibitory action of E3810 on H+, K+-ATPase and gastric acid secretion in vitro.. Folia Pharmacologica Japonica. 102(6). 389–397. 12 indexed citations
8.
Fujisaki, Hideaki, Hajime Shibata, Kiyoshi Oketani, et al.. (1991). Inhibitions of acid secretion by E3810 and omeprazole, and their reversal by glutathione. Biochemical Pharmacology. 42(2). 321–328. 85 indexed citations
9.
Nishizawa, Yukio, et al.. (1987). Effects of taurocholic acid/HCl alone or after pretreatment with geranylgeranylacetone on phospholipid metabolism in rat gastric mucosa. Biochemical Pharmacology. 36(23). 4111–4117. 9 indexed citations
10.
Murakami, Manabu, Hideaki Fujisaki, Kiyoshi Oketani, & Tsuneo Wakabayashi. (1985). Effect of secretin on stress-induced gastric bleeding in rats. Digestive Diseases and Sciences. 30(4). 346–352. 6 indexed citations
11.
Fujisaki, Hideaki, Kiyoshi Oketani, Manabu Murakami, et al.. (1984). Synthesis and gastric antisecretory activity of N-cyano-N'-(phenyl-pyridinylmethyl)guanidine derivatives.. Chemical and Pharmaceutical Bulletin. 32(12). 4893–4906. 1 indexed citations
12.
Oketani, Kiyoshi, Manabu Murakami, Hideaki Fujisaki, Tsuneo Wakabayashi, & Kyoko Hotta. (1983). Effect of geranylgeranylacetone on aspirin-induced changes in gastric glycoproteins.. The Japanese Journal of Pharmacology. 33(3). 593–601. 29 indexed citations
13.
Murakami, Manabu, Kiyoshi Oketani, Hideaki Fujisaki, et al.. (1983). Effect of synthetic acyclic polyisoprenoids on the cold-restraint stress induced gastric ulcer in rats.. The Japanese Journal of Pharmacology. 33(3). 549–556. 10 indexed citations
14.
Oketani, Kiyoshi, Manabu Murakami, Hideaki Fujisaki, Tsuneo Wakabayashi, & Kyôko Hotta. (1983). EFFECT OF GERANYLGERANYLACETONE ON ASPIRIN-INDUCED CHANGES IN GASTRIC GLYCOPROTEINS. The Japanese Journal of Pharmacology. 33(3). 593–601. 3 indexed citations
15.
Murakami, Manabu, Kiyoshi Oketani, Hideaki Fujisaki, & Tsuneo Wakabayashi. (1982). Effect of geranylgeranylacetone (GGA) on gastric lesions induced by topical aspirin plus HCl.. The Japanese Journal of Pharmacology. 32(5). 921–924. 15 indexed citations
16.
Murakami, Manabu, Kiyoshi Oketani, Hideaki Fujisaki, & Tsuneo Wakabayashi. (1982). EFFECT OF GERANYLGERANYLACETONE (GGA) ON GASTRIC LESIONS INDUCED BY TOPICAL ASPIRIN PLUS HCl. The Japanese Journal of Pharmacology. 32(5). 921–924. 2 indexed citations
17.
Murakami, Manabu, et al.. (1982). Effects of the antiulcer drug geranylgeranylacetone on aspirin-induced gastric ulcers in rats.. The Japanese Journal of Pharmacology. 32(2). 299–306. 38 indexed citations
18.
Murakami, Manabu, et al.. (1982). EFFECTS OF THE ANTIULCER DRUG GERANYLGERANYLACETONE ON ASPIRIN-INDUCED GASTRIC ULCERS IN RATS. The Japanese Journal of Pharmacology. 32(2). 299–306. 6 indexed citations
19.
Murakami, Manabu, et al.. (1981). Antiulcer effect of geranylgeranylacetone, a new acyclic polyisoprenoid on experimentally induced gastric and duodenal ulcers in rats.. PubMed. 31(5). 799–804. 84 indexed citations
20.
Yorifuji, Takamitsu, et al.. (1979). Guanidinoacetate amidinohydrolase from a Flavobacterium purification, crystallization and properties.. Agricultural and Biological Chemistry. 43(1). 55–62. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Fryklund Breakdown of academic impact, for papers by B. Elander Breakdown of academic impact, for papers by Wen Yan Breakdown of academic impact, for papers by M Armstrong Breakdown of academic impact, for papers by Bob D. Rush Breakdown of academic impact, for papers by Akifumi Kogame Breakdown of academic impact, for papers by Carolina Cerré Breakdown of academic impact, for papers by Colin J. Theobald Breakdown of academic impact, for papers by Marie Besancon Breakdown of academic impact, for papers by Ulrike Gutjahr
Rankless by CCL
2026